Interestingly, NDRG1-high and ER-negative tumors were associated with the worst clinical outcomes for patients with IBC (OS, p = 0.0003; DSS, p = 0.0003; Figure 3c,d). Here, NDRG1 is linked to inflammatory breast carcinoma.